Patent ID: 8252806

Claim:
A pyrazolyl-quinazoline compound of Formula I or a pharmaceutically acceptable salt thereof, wherein n is 0 or 1; X represents 0, S or NR′; wherein R′ represents hydrogen or alkyl; Y represents alkyl or alkenyl, or a monocyclic or polycyclic, carbocyclic group selected from cycloalkyl, phenyl, naphthyl, 1,2,3,4-tetrahydro-naphthyl and indanyl, or a monocyclic or polycyclic heterocyclic group selected from pyridinyl, indolyl tetrahydro-pyranyl and guinolinyl, or heterocyclic group, which carbocyclic or heterocyclic groups may optionally be substituted one or more times with substituents selected from the group consisting of alkyl, halo, haloalkyl, alkoxy, methylenedioxy, phenyl and morpholinyl; or, when n is 0 and X is NR′, Y together with R′ and together with the nitrogen to which they are attached form a piperidinyl ring; and R 1 , R 2 and R 3 independently of each other, represent hydrogen or alkyl.